Cargando…

Ciclopirox Olamine Exerts Tumor-Suppressor Effects via Topoisomerase II Alpha in Lung Adenocarcinoma

BACKGROUND: Globally, lung cancer is one of the most malignant tumors, of which lung adenocarcinoma (LUAD) is the most common subtype, with a particularly poor prognosis. Ciclopirox olamine (CPX) is an antifungal drug and was recently identified as a potential antitumor agent. However, how CPX and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Jie, Che, Gang, Jiang, Kan, Zhou, Ziyang, Wu, Lingyun, Xu, Mengyou, Liu, Jian, Yan, Senxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894728/ https://www.ncbi.nlm.nih.gov/pubmed/35251970 http://dx.doi.org/10.3389/fonc.2022.791916

Ejemplares similares

Topical Ciclopirox Olamine 1%: Revisiting a Unique Antifungal
por: Sonthalia, Sidharth, et al.
Publicado: (2019)

3508 Ciclopirox Olamine Demonstrates Inhibitory Effects on Esophageal Tumor Cells
por: Ryan, Randi, et al.
Publicado: (2019)

Ciclopirox Olamine Induces Proliferation Inhibition and Protective Autophagy in Hepatocellular Carcinoma
por: Wan, Xinyan, et al.
Publicado: (2023)

Antimycotic Ciclopirox Olamine in the Diabetic Environment Promotes Angiogenesis and Enhances Wound Healing
por: Ko, Sae Hee, et al.
Publicado: (2011)

Repurposing antimycotic ciclopirox olamine as a promising anti-ischemic stroke agent
por: Feng, Hongxuan, et al.
Publicado: (2020)

Ciclopirox olamine induces ferritinophagy and reduces cyst burden in polycystic kidney disease
por: Radadiya, Priyanka S., et al.
Publicado: (2021)

Assessment of Physical, Mechanical, Biopharmaceutical Properties of Emulgels and Bigel Containing Ciclopirox Olamine
por: Mazurkevičiūtė, Agnė, et al.
Publicado: (2022)

Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models
por: Mihailidou, Chrysovalantou, et al.
Publicado: (2017)

High-Throughput Drug Screening Revealed That Ciclopirox Olamine Can Engender Gastric Cancer Stem-like Cells
por: Pádua, Diana, et al.
Publicado: (2023)

Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines
por: Wu, Jianrong, et al.
Publicado: (2016)

Expression of topoisomerase II alpha and beta in an adenocarcinoma cell line carrying amplified topoisomerase II alpha and retinoic acid receptor alpha genes.
por: Coutts, J., et al.
Publicado: (1993)

STC2 activates PRMT5 to induce radioresistance through DNA damage repair and ferroptosis pathways in esophageal squamous cell carcinoma
por: Jiang, Kan, et al.
Publicado: (2023)

Mucinous Prostate Cancer Shows Similar Prognosis to Typical Prostate Acinar Carcinoma: A Large Population-Based and Propensity Score-Matched Study
por: Zhao, Feng, et al.
Publicado: (2020)

Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
por: do Couto, Fabíola Maria Marques, et al.
Publicado: (2016)

Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics
por: Matias-Barrios, Victor M., et al.
Publicado: (2021)

A Novel Copper(II) Indenoisoquinoline Complex Inhibits Topoisomerase I, Induces G2 Phase Arrest, and Autophagy in Three Adenocarcinomas
por: Molinaro, Caroline, et al.
Publicado: (2022)

Amorolfine vs. ciclopirox – lacquers for the treatment of onychomycosis
por: Tabara, Katarzyna, et al.
Publicado: (2015)

The Significance of Topoisomerase II Alpha in Invasive Breast Carcinoma
por: Arthi, M, et al.
Publicado: (2021)

A novel hydrogel orthotopic injection model in moderately hypofractionated radiation therapy for prostate cancer: Adaptive degradation and durable imaging
por: Yu, Hao, et al.
Publicado: (2023)

Targeting DNA Homologous Repair Proficiency With Concomitant Topoisomerase II and c-Abl Inhibition
por: Siddiqui, Arafat, et al.
Publicado: (2021)

Investigating the Anticancer Potential of Salvicine as a Modulator of Topoisomerase II and ROS Signaling Cascade
por: Dey, Dipta, et al.
Publicado: (2022)

Maternal topoisomerase II alpha, not topoisomerase II beta, enables embryonic development of zebrafish top2a(-/- )mutants
por: Sapetto-Rebow, Beata, et al.
Publicado: (2011)

Synthetic Derivatives of Ciclopirox are Effective Inhibitors of Cryptococcus neoformans
por: Lin, Jeffrey, et al.
Publicado: (2021)

Identification of IFN-Induced Transmembrane Protein 1 With Prognostic Value in Pancreatic Cancer Using Network Module-Based Analysis
por: Wu, Lingyun, et al.
Publicado: (2021)

Prognostic implications of necroptosis-related long noncoding RNA signatures in muscle-invasive bladder cancer
por: Jiang, Kan, et al.
Publicado: (2022)

Expression of the Topoisomerase II Alpha (TOP2A) Gene in Lung Adenocarcinoma Cells and the Association with Patient Outcomes
por: Du, Xiaomei, et al.
Publicado: (2020)

CD26/dipeptidyl peptidase IV enhances expression of topoisomerase II alpha and sensitivity to apoptosis induced by topoisomerase II inhibitors
por: Sato, K, et al.
Publicado: (2003)

KDM5C Represses FASN-Mediated Lipid Metabolism to Exert Tumor Suppressor Activity in Intrahepatic Cholangiocarcinoma
por: Zhang, Bo, et al.
Publicado: (2020)

Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta gene as a tumour suppressor in stomach adenocarcinoma
por: Li, Yun, et al.
Publicado: (2022)

Regulation of the catalytic function of topoisomerase II alpha through association with RNA
por: Park, Seung-Won, et al.
Publicado: (2008)

Id2 exerts tumor suppressor properties in lung cancer through its effects on cancer cell invasion and migration
por: Chen, Jian-Ting, et al.
Publicado: (2022)

Sugar and iron: Toward understanding the antibacterial effect of ciclopirox in Escherichia coli
por: Conley, Zachary C., et al.
Publicado: (2019)

Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly
por: Kang, Jung-Ah, et al.
Publicado: (2019)

Ciclopirox inhibits cancer cell proliferation by suppression of Cdc25A
por: Shen, Tao, et al.
Publicado: (2017)

Improving the Pharmacological Properties of Ciclopirox for Its Use in Congenital Erythropoietic Porphyria
por: Bernardo-Seisdedos, Ganeko, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells in Immune Microenvironment Promote Progression of Esophagogastric Junction Adenocarcinoma
por: Wang, Ying, et al.
Publicado: (2021)

Differential expression of the topoisomerase II alpha and beta genes in human breast cancers.
por: Sandri, M. I., et al.
Publicado: (1996)

The deubiquitylase USP15 regulates topoisomerase II alpha to maintain genome integrity
por: Fielding, Andrew B., et al.
Publicado: (2018)

The Impact of the C-Terminal Region on the Interaction of Topoisomerase II Alpha with Mitotic Chromatin
por: Antoniou-Kourounioti, Melissa, et al.
Publicado: (2019)

Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma
por: Liu, Hailiang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2mj84u90k3b6g17q3a8pb04ij7